Translating Research for the Radiotheranostics of Nanotargeted
Animals
Clinical Studies as Topic
Drug Evaluation, Preclinical
Humans
Liposomes
/ chemistry
Nanoparticles
/ chemistry
Neoplasms
/ diagnostic imaging
Outcome Assessment, Health Care
Radioisotopes
Radiometry
Radiopharmaceuticals
/ chemistry
Rhenium
Single Photon Emission Computed Tomography Computed Tomography
Theranostic Nanomedicine
/ methods
Tissue Distribution
Tomography, Emission-Computed, Single-Photon
Translational Research, Biomedical
/ methods
liposome
nanoliposome
nuclear imaging
radiotheranostics
rhenium-188
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
08 Apr 2021
08 Apr 2021
Historique:
received:
18
03
2021
revised:
29
03
2021
accepted:
30
03
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
25
5
2021
Statut:
epublish
Résumé
Nanoliposomes are one of the leading potential nano drug delivery systems capable of targeting chemotherapeutics to tumor sites because of their passive nano-targeting capability through the enhanced permeability and retention (EPR) effect for cancer patients. Recent advances in nano-delivery systems have inspired the development of a wide range of nanotargeted materials and strategies for applications in preclinical and clinical usage in the cancer field. Nanotargeted
Identifiants
pubmed: 33918011
pii: ijms22083868
doi: 10.3390/ijms22083868
pmc: PMC8068325
pii:
doi:
Substances chimiques
Liposomes
0
Radioisotopes
0
Radiopharmaceuticals
0
Rhenium-188
229C124H5I
Rhenium
7440-15-5
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Front Immunol. 2017 May 26;8:613
pubmed: 28603525
Methods Mol Biol. 2017;1522:155-178
pubmed: 27837538
Expert Rev Med Devices. 2020 Apr;17(4):331-343
pubmed: 32157920
Nucl Med Biol. 2007 May;34(4):415-23
pubmed: 17499731
Mol Clin Oncol. 2014 May;2(3):380-384
pubmed: 24772304
CA Cancer J Clin. 2007 May-Jun;57(3):168-85
pubmed: 17507442
Adv Drug Deliv Rev. 2020;156:4-22
pubmed: 32593642
J Nucl Med. 2001 Mar;42(3):499-504
pubmed: 11337529
Clin Cancer Res. 2001 Feb;7(2):243-54
pubmed: 11234875
J Nucl Med. 2005 Jan;46 Suppl 1:18S-27S
pubmed: 15653648
Molecules. 2020 Aug 08;25(16):
pubmed: 32784458
Nucl Med Biol. 1998 Nov;25(8):733-6
pubmed: 9863558
Eur J Nucl Med Mol Imaging. 2016 May;43(5):938-940
pubmed: 26743898
J Appl Toxicol. 2013 Sep;33(9):886-93
pubmed: 22535684
Int J Mol Sci. 2017 Apr 25;18(5):
pubmed: 28441355
Nucl Med Biol. 2014 Oct;41(9):765-71
pubmed: 25027866
Oncol Rep. 2012 Mar;27(3):678-84
pubmed: 22109644
Anticancer Res. 2009 Oct;29(10):4107-18
pubmed: 19846958
J Nucl Med. 2015 Jun;56(6):897-900
pubmed: 25931476
Int J Radiat Biol. 2017 May;93(5):477-486
pubmed: 28045339
Drug Chem Toxicol. 2011 Jan;34(1):20-4
pubmed: 21121875
Eur J Nucl Med Mol Imaging. 2003 Sep;30(9):1251-61
pubmed: 12830326
Radiother Oncol. 2016 May;119(2):282-90
pubmed: 26915312
Nucl Med Biol. 2008 Nov;35(8):883-93
pubmed: 19026950
Appl Radiat Isot. 1996 Mar;47(3):267-71
pubmed: 8935963
Oncology. 2010;78(3-4):237-48
pubmed: 20523084
Int J Nanomedicine. 2015 May 19;10:3641-9
pubmed: 26056445
Cell Death Discov. 2018 Oct 31;4:100
pubmed: 30393570
Science. 2004 Mar 19;303(5665):1818-22
pubmed: 15031496
Cancer Biother Radiopharm. 2012 Oct;27(8):481-9
pubmed: 23067100
Front Med (Lausanne). 2019 Jun 14;6:132
pubmed: 31259173
Int J Mol Sci. 2021 Feb 14;22(4):
pubmed: 33672989
Anticancer Res. 2007 Jul-Aug;27(4B):2217-25
pubmed: 17695506
J Biomed Biotechnol. 2010;2010:
pubmed: 20811605
Invest New Drugs. 2013 Aug;31(4):801-11
pubmed: 23224353
J Nucl Med. 2005 Jun;46(6):1023-7
pubmed: 15937315
Nucl Med Biol. 2010 Nov;37(8):927-34
pubmed: 21055623
Cancer Biother Radiopharm. 2011 Dec;26(6):717-25
pubmed: 22145660
Anticancer Res. 2010 Jan;30(1):65-72
pubmed: 20150618
Int J Mol Sci. 2019 May 10;20(9):
pubmed: 31083402
Expert Opin Drug Deliv. 2016 Sep;13(9):1231-42
pubmed: 27351233
Expert Rev Gastroenterol Hepatol. 2008 Feb;2(1):135-49
pubmed: 19072376
EJNMMI Res. 2019 May 22;9(1):46
pubmed: 31119414
Gastroenterology. 2008 May;134(5):1296-310
pubmed: 18471507
Nucl Med Biol. 2012 Jan;39(1):35-43
pubmed: 21958858
Oncotarget. 2016 Oct 4;7(40):65782-65796
pubmed: 27588466
J Nucl Med. 2003 Dec;44(12):1992-9
pubmed: 14660726
Nucl Med Biol. 2010 Jan;37(1):95-104
pubmed: 20122674
Radiology. 2002 Apr;223(1):76-82
pubmed: 11930050
Int J Nanomedicine. 2011;6:2607-19
pubmed: 22114492
Int J Mol Sci. 2021 Jan 22;22(3):
pubmed: 33499267
Int J Nanomedicine. 2015 Jan 09;10:463-73
pubmed: 25624760
Regul Toxicol Pharmacol. 2014 Jul;69(2):217-25
pubmed: 24721389
Molecules. 2018 Jan 30;23(2):
pubmed: 29385755
J Control Release. 2012 Jul 20;161(2):328-37
pubmed: 22626940
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
J Appl Toxicol. 2010 Oct;30(7):680-7
pubmed: 20981861
Acc Chem Res. 2011 Oct 18;44(10):1029-38
pubmed: 21545096
Cancer Biother Radiopharm. 2008 Dec;23(6):749-58
pubmed: 19111045
Adv Drug Deliv Rev. 2019 Mar 15;143:134-160
pubmed: 31170428
Nucl Med Biol. 2011 Feb;38(2):207-13
pubmed: 21315276
Appl Radiat Isot. 2015 May;99:117-21
pubmed: 25748057
J Nucl Med. 2014 Nov;55(11):1864-70
pubmed: 25349220
Anticancer Res. 2015 Sep;35(9):4777-88
pubmed: 26254368
Nat Rev Drug Discov. 2005 Feb;4(2):145-60
pubmed: 15688077